Show simple item record

dc.contributor.authorRamage, J
dc.contributor.authorPunia, P
dc.contributor.authorFaluyi, O
dc.contributor.authorFrilling, A
dc.contributor.authorMeyer, T
dc.contributor.authorKapur, G
dc.contributor.authorCave, J
dc.contributor.authorWadsley, J
dc.contributor.authorCummins, S
dc.contributor.authorFarrugia, D
dc.contributor.authorStarling, N
dc.contributor.authorWall, L
dc.contributor.authorSaharan, R
dc.contributor.authorValle, Juan W
dc.date.accessioned2017-04-23T20:06:42Z
dc.date.available2017-04-23T20:06:42Z
dc.date.issued2016-10-01
dc.identifier.citationUK phase IV, observational study to assess quality of life in patients (pts) with pancreatic neuroendocrine tumours (pNETS) receiving treatment with everolimus: the “real-world” OBLIQUE study. 2016, 27(suppl_6):437P Annals of Oncologyen
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.doi10.1093/annonc/mdw369.22
dc.identifier.urihttp://hdl.handle.net/10541/620274
dc.language.isoenen
dc.relation.urlhttps://academic.oup.com/annonc/article/2799176/UKen
dc.rightsArchived with thanks to Annals of Oncologyen
dc.titleUK phase IV, observational study to assess quality of life in patients (pts) with pancreatic neuroendocrine tumours (pNETS) receiving treatment with everolimus: the “real-world” OBLIQUE study.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentInstitute of Liver Studies, King’s College Hospital, Londonen
dc.identifier.journalAnnals of Oncologyen


This item appears in the following Collection(s)

Show simple item record